| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.48 | 0.1 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.08 | 0.1 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.1 |